Giant Cell Arteritis: A Systematic Review of the Qualitative and Semiquantitative Methods to Assess Vasculitis with 18F-Fluorodeoxyglucose Positron Emission Tomography

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Puppo, Cristina ^a   Massollo, Michela ^a   Paparo, Francesco ^a   Camellino, Dario ^b   Piccardo, Arnoldo ^a   Shoushtari Zadeh Naseri, Mehrdad ^a   Villavecchia, Giampiero ^a   Rollandi, Gian Andrea ^a   Cimmino, Marco Amedeo ^b  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL AORTA; ARTICLE; ATHEROSCLEROSIS; AXILLARY ARTERY; CAROTID ARTERY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMORAL ARTERY; GIANT CELL ARTERITIS; HUMAN; ILIAC ARTERY; INTERNAL JUGULAR VEIN; MAMMARY ARTERY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SHOULDER; SUBCLAVIAN ARTERY; SYSTEMATIC REVIEW; THORACIC AORTA; VENOUS BLOOD; DIAGNOSTIC USE; INFLAMMATION; PATHOLOGY; PROCEDURES; RADIOGRAPHY; RHEUMATIC POLYMYALGIA; VASCULITIS;

AORTA, THORACIC; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; INFLAMMATION; POLYMYALGIA RHEUMATICA; POSITRON-EMISSION TOMOGRAPHY; VASCULITIS;

EID: 84929286955     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/574248     Document Type: Article

References (60)

1. C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder, "Polymyalgia rheumatica and giant-cell arteritis, " New England Journal of Medicine, vol. 347, no. 4, pp. 261-271, 2002.
2. M. A. Gonzalez-Gay, C. Garcia-Porrua, J. A. Miranda-Filloy, and J. Martin, "Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management, " Drugs and Aging, vol. 23, no. 8, pp. 627-649, 2006.
3. D. M. Nuenninghof f, G. G. Hunder, T. J. H. Christianson, R. L. McClelland, and E. L. Matteson, "Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and /or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years, " Arthritis and Rheumatism, vol. 48, no. 12, pp. 3522-3531, 2003.
4. J. M. Evans, W. M. OFallon, and G. G. Hunder, "Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study, " Annals of Internal Medicine, vol. 122, no. 7, pp. 502-507, 1995.
5. T. Bongartz and E. L. Matteson, "Large-vessel involvement in giant cell arteritis, " Current Opinion in Rheumatology, vol. 18, no. 1, pp. 10-17, 2006.
6. S. Barber, "Myalgic syndrome with constitutional effects, " Annals of the Rheumatic Diseases, vol. 16, pp. 230-237, 1957.
7. J. M. Evans and G. G. Hunder, "Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985, " Arthritis and Rheumatism, vol. 30, no. 3, pp. 294-299, 1987.
8. C. Schaufelberger, B.-A. Bengtsson, and R. Andersson, "Epidemiology and mortality in 220 patients with polymyalgia rheumatica, " British Journal of Rheumatology, vol. 34, no. 3, pp. 261-264, 1995.
9. P. Elling, A. T. Olsson, and H. Elling, "Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection, " Journal of Rheumatology, vol. 23, no. 1, pp. 112-119, 1996.
10. F. Cantini, L. Niccoli, L. Storri, et al., "Arepolymyalgia rheumatic and giant cell arteritis the same disease?" Seminars in Arthritis and Rheumatism, vol. 33, no. 5, pp. 294-301, 2004.
11. C. Salvarani, C. S. Crowson, W. M. OFallon, G. G. Hunder, and S. E. Gabriel, "Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period, " Arthritis Care and Research, vol. 51, no. 2, pp. 264-268, 2004.
12. E. Nordborg and C. Nordborg, "Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment, " Rheumatology, vol. 42, no. 3, pp. 413-421, 2003.
13. J. T. Gran and G. Myklebust, "The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: a prospective study 1987-94, " The Journal of Rheumatology, vol. 24, no. 9, pp. 1739-1743, 1997.
14. P. Franzen, S. Sutinen, and J. von Knorring, "Giant cell arteritis and polymyalgia rheumatica in a region of Finland : an epidemiologic, clinical and pathologic study, 1984-1988, " Journal of Rheumatology, vol. 19, no. 2, pp. 273-280, 1992.
15. C. Salvarani, L. Boiardi, V. Mantovani, et al., "HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity, " Annals of the Rheumatic Diseases, vol. 58, no. 5, pp. 303-308, 1999.
16. M. A. Gonzalez-Gay, M. M. Amoli, C. Garcia-Porrua, and W. E. R. Ollier, "Geneticmarkers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica, " Seminars in Arthritis and Rheumatism, vol. 33, no. 1, pp. 38-48, 2003.
17. M. Bas-Lando, G. S. Breuer, Y. Berkun, M. Mates, M. Sonnenblick, and G. Nesher, "The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations, " Clinical and Experimental Rheumatology, vol. 25, supplement 44, no. 1, pp. S15-S17, 2007.
18. P. Duhaut, S. Bosshard, and J.-P. Ducroix, "Is giant cell arteritis an infectious disease? Biological and epidemiological evidence, " Presse Medicale, vol. 33, no. 19, pp. 1403-1408, 2004.
19. C. Salvarani, F. Cantini, and G. G. Hunder, "Polymyalgia rheumatica and giant-cell arteritis, " The Lancet, vol. 372, no. 9634, pp. 234-245, 2008.
20. M. A. Gonzalez-Gay, C. Garcia-Porrua, A. Pineiro, R. Pego-Reigosa, J. Llorca, and G. G. Hunder, "Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis fromNorthwestern Spain: a population-based study, " Medicine, vol. 83, no. 6, pp. 335-341, 2004.
21. D. Blockmans, L. de Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers, "Repetitive 18Ffluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients, " Arthritis Care and Research, vol. 55, no. 1, pp. 131-137, 2006.
22. S. Prieto-Gonzalez, P. Arguis, A. Garcia-Martinez, et al., "Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography, " Annals of the Rheumatic Diseases, vol. 71, no. 7, pp. 1170-1176, 2012.
23. M. Aschwanden, F. Kesten, M. Stern, et al., "Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions, " Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1356-1359, 2010.
24. S. Prieto-Gonzalez, M. Depetris, A. Garcia-Martinez, et al., "Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study, " Annals of the Rheumatic Diseases, vol. 73, no. 7, pp. 1388-1392, 2014.
25. D. Blockmans, A. Maes, S. Stroobants, et al., "New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography, " Rheumatology, vol. 38, no. 5, pp. 444-447, 1999.
26. D. Blockmans, S. Stroobants, A. Maes, and L. Mortelmans, "Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch, " The American Journal of Medicine, vol. 108, no. 3, pp. 246-249, 2000.
27. J. Meller, F. Strutz, U. Siefker, et al., "Early diagnosis and followup of aortitis with 18F]FDG PET and MRI, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 5, pp. 730-736, 2003.
28. C. P. Bleeker-Rovers, S. J. H. Bredie, J. W. M. van der Meer, F. H. M. Corstens, and W. J. G. Oyen, "F-I8-fluorodeoxyglucose positron emmission tomography in diagnosis and follow-up of patients with different types of vasculitis, " Netherlands Journal of Medicine, vol. 61, no. 10, pp. 323-329, 2003.
29. F. Moosig, N. Czech, C. Mehl, et al., "Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study, " Annals of the Rheumatic Diseases, vol. 63, no. 7, pp. 870-873, 2004.
30. M. Brodmann, R. W. Lipp, A. Passath, G. Seinost, E. Pabst, and E. Pilger, "The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries, " Rheumatology, vol. 43, no. 2, pp. 241-242, 2004.
31. A. K. Scheel, J. Meller, R. Vosshenrich, et al., "Diagnosis and follow up of aortitis in the elderly, " Annals of the Rheumatic Diseases, vol. 63, no. 11, pp. 1507-1510, 2004.
32. M. A. Walter, R. A. Melzer, C. Schindler, J. Muller-Brand, A. Tyndall, and E. U. Nitzsche, "The value of 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease, " European Journal of NuclearMedicine and Molecular Imaging, vol. 32, no. 6, pp. 674-681, 2005.
33. D. Blockmans, L. de Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers, "Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients, " Rheumatology, vol. 46, no. 4, pp. 672-677, 2007.
34. J. C. Henes, M. Muller, J. Krieger, et al., "18F FDG-PET/CT as a new and sensitive imaging method for the diagnosis of largevessel vasculitis, " Clinical and Experimental Rheumatology, vol. 26, supplement 49, no. 3, pp. S47-S52, 2008.
35. H. Hautzel, O. Sander, A. Heinzel, M. Schneider, and H. Muller, "Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutof f ratio, " Journal of Nuclear Medicine, vol. 49, no. 7, pp. 1107-1113, 2008.
36. M. Both, K. Ahmadi-Simab, M. Reuter, et al., "MRI and FDGPET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis, " Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1030-1033, 2008.
37. P. Lehmann, S. Buchtala, N. Achajew, et al., "18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans, " Clinical Rheumatology, vol. 30, no. 1, pp. 37-42, 2011.
38. J. C. Henes, M. Mueller, C. Pfannenberg, L. Kanz, and I. Koetter, "Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT, " Clinical and Experimental Rheumatology, vol. 29, no. 1, supplement 64, pp. S43-S48, 2011.
39. G. A. Hooisma, H. Balink, P. M. Houtman, R. H. J. A. Slart, and K. D. F. Lensen, "Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study, " Clinical Rheumatology, vol. 31, no. 5, pp. 861-871, 2012.
40. H. Yamashita, K. Kubota, Y. Takahashi, et al., "Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis, " Modern Rheumatology, vol. 22, no. 5, pp. 705-711, 2012.
41. F. L. Besson, H. de Boysson, J. Parienti, G. Bouvard, B. Bienvenu, and D. Agostini, "Towards an optimal semiquantitative approach in giant cell arteritis: an 18F-FDG PET/CT case-control study, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 1, pp. 155-166, 2013.
42. M. Tatsumi, C. Cohade, Y. Nakamoto, and R. L. Wahl, "Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis, " Radiology, vol. 229, no. 3, pp. 831-837, 2003.
43. G. G. Hunder, D. A. Bloch, B. A. Michel, et al., "The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, " Arthritis and Rheumatism, vol. 33, no. 8, pp. 1122-1128, 1990.
44. D. M. Nuenninghof f, G. G. Hunder, T. J. H. Christianson, R. L. McClelland, and E. L. Matteson, "Incidence and predictors of aortic aneurysm, aortic dissection and large artery stenosis in patients with giant cell arteritis in Olmsted county, MN, over a 50-year period, " Arthritis & Rheumatology, vol. 46, supplement 9, p. S183, 2002.
45. E. W. T. Chong and A. J. Robertson, "Is temporal artery biopsy a worthwhile procedure?" ANZ Journal of Surgery, vol. 75, no. 6, pp. 388-391, 2005.
46. R. Taylor-Gjevre, M. Vo, D. Shukla, and L. Resch, "Temporal artery biopsy for giant cell arteritis, " Journal of Rheumatology, vol. 32, no. 7, pp. 1279-1282, 2005.
47. A. M. Roth, L. Milsow, and J. L. Keltner, "Theultimatediagnoses of patients undergoing temporal artery biopsies, " Archives of Ophthalmology, vol. 102, no. 6, pp. 901-903, 1984.
48. M. A. Gonzalez-Gay, C. Garcia-Porrua, J. Llorca, C. Gonzalez-Louzao, and P. Rodriguez-Ledo, "Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy, " Seminars in Arthritis and Rheumatism, vol. 30, no. 4, pp. 249-256, 2001.
49. S. Hall, S. Persellin, J. T. Lie, P. C. O'Brien, L. T. Kurland, and G. G. Hunder, "The therapeutic impact of temporal artery biopsy, " The Lancet, vol. 2, no. 8361, pp. 1217-1220, 1983.
50. R. C. Brooks and S. R. McGee, "Diagnostic dilemmas in polymyalgia rheumatica, " Archives of Internal Medicine, vol. 157, no. 2, pp. 162-168, 1997.
51. F. L. Besson, J. Parienti, B. Bienvenu, et al., "Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and metaanalysis, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 9, pp. 1764-1772, 2011.
52. W. A. Schmidt, A. Seifert, E. Gromnica-ihle, A. Krause, and A. Natusch, "Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis, " Rheumatology, vol. 47, no. 1, pp. 96-101, 2008.
53. C. Agard, J. Barrier, B. Dupas, et al., "Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan, " Arthritis Care and Research, vol. 59, no. 5, pp. 670-676, 2008.
54. A. Brack, V. Martinez-Taboada, A. Stanson, J. J. Goronzy, and C. M. Weyand, "Disease pattern in cranial and large-vessel giant cell arteritis, " Arthritis & Rheumatology, vol. 42, pp. 311-317, 1999.
55. M. A. Cimmino, D. Camellino, F. Paparo, et al., "High frequency of capsular knee involvement in polymyalgia rheumatica /giant cell arteritis patients studied by positron emission tomography, " Rheumatology, vol. 52, no. 10, pp. 1865-1872, 2013.
56. F. Jamar, J. Buscombe, A. Chiti, et al., "EANM/SNMMIguideline for 18F-FDG use in inflammation and infection, " Journal of Nuclear Medicine, vol. 54, no. 4, pp. 647-658, 2013.
57. J. H. F. Rudd, K. S. Myers, S. Bansilal, et al., "Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations, " Journal of NuclearMedicine, vol. 49, no. 6, pp. 871-878, 2008.
58. M. P. S. Dunphy, A. Freiman, S. M. Larson, and H. W. Strauss, "Association of vascular 18F-FDG uptake with vascular calcification, " Journal of Nuclear Medicine, vol. 46, no. 8, pp. 1278-1284, 2005.
59. M. Yun, S. Jang, A. Cucchiara, A. B. Newberg, and A. Alavi, "18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors, " Seminars in Nuclear Medicine, vol. 32, no. 1, pp. 70-76, 2002.
60. T. Belhocine, D. Blockmans, R. Hustinx, J. Vandevivere, and L. Mortelmans, "Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 9, pp. 1305-1313, 2003.